… of drug therapies for frontotemporal dementia spectrum … of frontotemporal dementia spectrum
disorders; second, a discussion of the challenges in the development of drug therapies third…

… Frontotemporal dementia (FTD) is the second most common form of dementia. It affects the
frontal … We also review the opportunities and challenges toward developing therapies and …

… a behavioral therapy called “routinizing therapy”—in which stimulus-bound and stereotypic
behaviors are replaced with appropriate behaviors—improved. This therapy was reported to …

… The frontotemporal dementia (FTD) spectrum is a heterogeneous group of neurodegenerative
syndromes with overlapping clinical, molecular and pathological features, all of which …

… frontotemporal lobar degeneration. This Review will use the term frontotemporal dementia
when focusing on the clinical syndromes of behavioural variant of frontotemporal dementia …

… by TDP-43 proteinopathy will benefit from neuroprotective therapies in the absence of clear
… therapeutic strategies that could benefit both tauopathies and TDP-43 proteinopathies. …

… Frontotemporal dementia is the second prevalent dementia after Alzheimer's disease. …
Efforts to raise PGRN levels are a therapeutic strategy for frontotemporal dementia. …

… therapies for the management of frontotemporal dementia (FTD)… Progress in obtaining approval
and therapeutic indications for … and publications investigating therapeutic options in FTD, …

… Introduction: Research into the pathogenic mechanisms behind frontotemporal dementia
(FTD) has yielded several new targets for therapeutic intervention; such targets include specific …

… Frontotemporal dementia (FTD) is a heterogeneous clinical entity that includes several
disorders characterized by different cellular mechanisms, involving different brain regions, with …